Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents

MLA

Juan Angel Jover, et al. “Hospital Admissions in Inflammatory Rheumatic Diseases during the Peak of COVID-19 Pandemic: Incidence and Role of Disease-Modifying Agents.” Therapeutic Advances in Musculoskeletal Disease, vol. 13, Feb. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b32c4fc6dba8e0f4a775c13da9183f5&authtype=sso&custid=ns315887.

APA

Juan Angel Jover, Esther Culebras, Leticia Leon, Benjamín Fernández-Gutiérrez, Lydia Abasolo, J. Font, Jose Ignacio Colome, Alfredo Madrid, Luis Rodriguez-Rodriguez, Dalifer Freites, & Arkaitz Mucientes. (2021). Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents. Therapeutic Advances in Musculoskeletal Disease, 13.

Chicago

Juan Angel Jover, Esther Culebras, Leticia Leon, Benjamín Fernández-Gutiérrez, Lydia Abasolo, J. Font, Jose Ignacio Colome, et al. 2021. “Hospital Admissions in Inflammatory Rheumatic Diseases during the Peak of COVID-19 Pandemic: Incidence and Role of Disease-Modifying Agents.” Therapeutic Advances in Musculoskeletal Disease 13 (February). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b32c4fc6dba8e0f4a775c13da9183f5&authtype=sso&custid=ns315887.